Antidepressant effect of stem cell-derived monoaminergic grafts
Cunningham MG, Donalds RA, Carlezon WA Jr, Hong S, Kim DS, Kim DW, Kim KS.
Laboratory for Neural Reconstruction,
McLean Hospital, Program in Neuroscience and Department of Psychiatry,
Harvard Medical School, Boston, Massachusetts, USA.
Neuroreport. 2007 Oct 29;18(16):1663-7.
ABSTRACTIn this study, we demonstrate that embryonic stem cells can be engineered to differentiate into high percentages of serotonergic and dopaminergic neurons. In vitro, these cells release serotonin and dopamine in response to membrane depolarization. Upon engraftment into the medial prefrontal cortex in rats, the homolog of the human anterior cingulate cortex, the cells assumed neuronal morphologies, expressed monoaminergic-specific proteins, and seemed to functionally integrate, as assessed by the upregulation of the immediate-early gene, cfos. Furthermore, the transplanted animals performed in a manner similar to that of animals that received the antidepressant, citalopram, when administered the forced swim test, a validated model of human depression. These results suggest that transplantation of customized stem cells might perhaps be useful in the study treatment of psychiatric disorders.JDTic
SNaRIs, NaSSAs, and NaRIs
CFR-1 antagonists: antalarmin
Stress, dynorphin, dysphoria and the kappa opioid system
and further reading
The Abolitionist Project
The Hedonistic Imperative
The Reproductive Revolution
Critique of Huxley's Brave New World
The Good Drug Guide
The Responsible Parent's Guide
To Healthy Mood Boosters For All The Family